http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103119057-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 |
| filingDate | 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103119057-B |
| titleOfInvention | Insulin prodrug based on amide |
| abstract | Provide the prodrug formulation of insulin and insulin analog, wherein insulin peptide have passed through amido link connect dipeptides prodrug element modify. Prodrug disclosed herein has at least 10 hours, be more typically greater than 2 hours, 20 hours and half-life of prolongation less than 70 hours, and non-enzymatic reaction by being driven by chemical instability changes into activity form in physiological conditions. |
| priorityDate | 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 711.